The Attitudes of Patients' Parents Receiving Allergen-Specific Immunotherapy Against Anaphylaxis

BERBER M., ERCAN SARIÇOBAN H., Ugras M., Ozen A.

ASTIM ALLERJI IMMUNOLOJI, cilt.20, sa.2, ss.71-76, 2022 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.21911/aai.602
  • Dergi Adı: ASTIM ALLERJI IMMUNOLOJI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.71-76
  • Anahtar Kelimeler: Parent attitude, anaphylaxis, immunotherapy, SCIT, children, SUBCUTANEOUS IMMUNOTHERAPY, FATAL REACTIONS, SURVEILLANCE, GUIDELINES, INJECTIONS, SAFETY, UPDATE, RISK
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective: Allergen immunotherapy (AIT) employs incremental amounts of an antigen to selected patients to promote clinical tolerance towards the offending allergen. The adverse reactions to AIT include local side effects such as induration in the field of application, itching and hyperemia, or systemic side effects such as shortness of breath, urticaria, hypotension, abdominal pain, vomiting and anaphylaxis. It is important that patients receiving AIT and their parents know about possible adverse reactions and can intervene when necessary. We aimed to assess the knowledge and attitudes towards anaphylaxis of the caregivers/parents of allergic children who receive subcutaneous immunotherapy (SCIT).